More

    Warning: Illegal string offset 'sidebar' in /home/customer/www/stocks.com.au/public_html/wp-content/themes/mining/functions.php on line 498

    Warning: Illegal string offset 'home' in /home/customer/www/stocks.com.au/public_html/wp-content/themes/mining/functions.php on line 498

    Warning: Illegal string offset 'home' in /home/customer/www/stocks.com.au/public_html/wp-content/themes/mining/functions.php on line 500

    Warning: Illegal string offset 'home' in /home/customer/www/stocks.com.au/public_html/wp-content/themes/mining/functions.php on line 504

    Warning: Illegal string offset 'sidebar' in /home/customer/www/stocks.com.au/public_html/wp-content/themes/mining/functions.php on line 516

    Warning: Illegal string offset 'home' in /home/customer/www/stocks.com.au/public_html/wp-content/themes/mining/functions.php on line 516

    Warning: Illegal string offset 'home' in /home/customer/www/stocks.com.au/public_html/wp-content/themes/mining/functions.php on line 518
    HomeHealthBiotech

    Biotech

    Biotech

    Noxopharm announces newly developed mRNA vaccine enhancer to further advance Sofra preclinical platform

    Adam Drought - 0
    Innovative biotech company Noxopharm (ASX:NOX) has developed a new proprietary product candidate based on mRNA technology as part of its Sofra preclinical platform. The company...
    Read more
    Biotech

    Memphasys enhances business development and sales capabilities with appointment of Dr David Ali

    Adam Drought - 0
    Australian-based reproductive biotechnology company Memphasys (ASX:MEM) has enhanced its business development and sales capabilities following the appointment of Dr David Ali as its Director...
    Read more
    Medical Cannabis

    Avecho Biotechnology expands oral cannabidiol clinical program with Lambert Initiative

    Adam Drought - 0
    Avecho Biotechnology (ASX:AVE) has expanded its clinical program being undertaken alongside leading Australian research group for cannabinoid therapeutics, the Lambert Initiative. The company says the...
    Read more
    Deals & Dollars

    Dimerix signs non-dilutive funding agreement to secure $2.8 million prepayment of R&D tax incentive

    Adam Drought - 0
    ASX-listed biopharmaceutical company Dimerix (ASX:DXB) reports it is set to receive $2.8 million following its entering into a non-dilutive funding agreement with Radium Capital...
    Read more
    Biotech

    Arovella Therapeutics moves to next stage with Imugene relationship

    Adam Drought - 0
    Biotechnology company Arovella Therapeutics (ASX:ALA) reports a successful in vitro outcome regarding its research collaboration with Imugene (ASX:IMU). The company says positive results, returned from...
    Read more
    Biotech

    Noxopharm delivers drug trial update for prostate cancer treatment candidate

    Adam Drought - 0
    Clinical stage drug development company Noxopharm (ASX:NOX) reports it has received confirmation from the DARRT-2 Safety Steering Committee that its VeyondaⓇ drug candidate is...
    Read more
    Biotech

    Nyrada delivers an update on brain injury program

    Adam Drought - 0
    Drug discovery and development company Nyrada (ASX:NYR) has provided an update on preclinical studies as part of its Brain Injury Program. The company says the...
    Read more
    Biotech

    AdAlta granted second patent for AD-214 in Japan

    Harry Mulholland - 0
    Melbourne-based biotechnology company AdAlta (ASX:1AD) reports it has been granted a second patent for its novel therapeutics product AD-214 in Japan. The company states the...
    Read more
    Deals & Dollars

    Proteomics extends LOI with Sonic Healthcare for PromarkerD technology

    Harry Mulholland - 0
    Perth-based medical technology company Proteomics International Laboratories (ASX:PIQ) reports it has extended the term of its letter of intent (LOI) with Sonic Healthcare (ASX:SHL)...
    Read more
    Biotech

    Immutep achieves commercial scale in manufacturing of Eftilagimod Alpha

    Harry Mulholland - 0
    Clinical stage biotechnology company Immutep (ASX:IMM) reports it has successfully achieved the commercial scale in manufacturing of its lead product candidate Eftilagimod (efti) Alpha. The...
    Read more
    Biotech

    Noxopharm reaches safety milestone with oncology drug candidate Veyonda

    Adam Drought - 0
    Australian biotech company Noxopharm (ASX:NOX) reports its lead oncology drug candidate Veyonda has passed a safety milestone from an ongoing IONIC Investigator-initiated pilot Phase...
    Read more
    Biotech

    Nanollose reports successful production of high-quality denim fabric using Nullarbor-20 fibre

    Adam Drought - 0
    Leading biomaterials company Nanollose (ASX:NC6) reports that Orta Anadolu Ticaret Ve Sanayi Isletmesi T.A.S (ORTA) has manufactured sample yardage of high-quality denim fabric containing...
    Read more
    Biotech

    Universal Biosensors’ Tn Antigen cancer biosensor published on ‘ACS Sensors’ front cover

    Adam Drought - 0
    ASX-listed global biosensor company Universal Biosensors (ASX:UBI) reports work conducted on its Tn Antigen cancer biosensor has been published in the American Chemical Society...
    Read more
    Deals & Dollars

    Medibio receives close to $1 million in R&D tax incentive refund

    Harry Mulholland - 0
    Medibio (ASX:MEB) reports it has received around $938,000 through its Research and Development Tax Incentive Refund for the 2021/202222 financial year. The company says the...
    Read more
    Biotech

    AVITA Medical receives FDA Breakthrough Device designation for its RECELL System

    Harry Mulholland - 0
    AVITA Medical (ASX:AVH) reports the Food and Drug Administration (FDA) has granted the RECELL System designations as a Breakthrough Device for its proposed soft...
    Read more
    Health

    CSL enters licencing agreement with Arcturus Therapeutics for next-gen mRNA Vaccine Technology

    Harry Mulholland - 0
    CSL (ASX:CSL) reports its subsidiary CSL Seqirus has entered into a collaboration and licence agreement with Arcturus Therapeutics to access their late stage self-amplifying...
    Read more
    Biotech

    Cynata joins forces with Leiden University Medical Centre for clinical trial of stem cell technology in kidney transplants

    Harry Mulholland - 0
    Cynata Therapeutics (ASX:CYP) reports it is collaborating with Leiden University Medical Centre (LUMC) in the Netherlands for a new clinical trial for the company’s...
    Read more

    Follow Us

    17,752FollowersFollow
    6,949FollowersFollow

    Stocks.com.au is published by Mayfair Media Operations Pty Ltd ABN 94 627 513 295. The information that we provide is general in nature and is not financial advice. Talk to a registered financial expert before making investment decisions.

    POPULAR POSTS

    POPULAR CATEGORY

    © 2022 Stocks.com.au - Australian Stock Market News